Uniquity Bio

Malvern, United States

Uniquity Bio is a clinical-stage drug development company focused on advancing scientific innovation and delivering novel medicines.

$300.0M raised

May 2024

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Uniquity Bio raised?

Uniquity Bio has raised $300.0M in total funding. The most recent round was Series A. The last funding was announced in May 2024.

Who are Uniquity Bio's investors?

Uniquity Bio's investors include Blackstone Life Sciences.

Where is Uniquity Bio headquartered?

Uniquity Bio is headquartered in Malvern, United States.

What does Uniquity Bio do?

Uniquity Bio is a clinical-stage drug development company focused on advancing scientific innovation and delivering novel medicines.

What stage is Uniquity Bio at?

Uniquity Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 15, 2024.

MLA

"Uniquity Bio — Funding & Investors." VCBacked, May 15, 2024, https://www.vcbacked.co/company/uniquity-bio. Accessed July 3, 2026.

APA

VCBacked. (2024). Uniquity Bio — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/uniquity-bio

Wikipedia (cite web)

{{cite web |title=Uniquity Bio — Funding & Investors |url=https://www.vcbacked.co/company/uniquity-bio |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 15, 2024.